Search

Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 120-133
Author(s): Bernhard A. Muller

Second Generation Abl Tyrosine Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone (Second Edition)

Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Shinya Kimura
Doi: 10.2174/978160805161811001010116

Targeting Cancer Using Fragment Based Drug Discovery

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 1 Year: 2012 Page: 40-48
Author(s): Andrew P. Turnbull, Susan M. Boyd

Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2146-2157
Author(s): X. Y. Lu, Q. Cai, K. Ding

Importance of Influx and Efflux Systems and Xenobiotic Metabolizing Enzymes in Intratumoral Disposition of Anticancer Agents

Journal: Current Cancer Drug Targets
Volume: 9 Issue: 5 Year: 2009 Page: 652-674
Author(s): B. Rochat